Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder.
Hoefgen B, Schulze TG, Ohlraun S, von Widdern O, Höfels S, Gross M, Heidmann V, Kovalenko S, Eckermann A, Kölsch H, Metten M, Zobel A, Becker T, Nöthen MM, Propping P, Heun R, Maier W, Rietschel M. Hoefgen B, et al. Biol Psychiatry. 2005 Feb 1;57(3):247-51. doi: 10.1016/j.biopsych.2004.11.027. Biol Psychiatry. 2005. PMID: 15691525
A possible genetic link between MTHFR genotype and smoking behavior.
Linnebank M, Moskau S, Semmler A, Hoefgen B, Bopp G, Kallweit U, Maier W, Schütz CG, Wüllner U. Linnebank M, et al. Among authors: hoefgen b. PLoS One. 2012;7(12):e53322. doi: 10.1371/journal.pone.0053322. Epub 2012 Dec 28. PLoS One. 2012. PMID: 23285280 Free PMC article.
Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
Hoefgen B, Decker M, Mohr P, Schramm AM, Rostom SA, El-Subbagh H, Schweikert PM, Rudolf DR, Kassack MU, Lehmann J. Hoefgen B, et al. J Med Chem. 2006 Jan 26;49(2):760-9. doi: 10.1021/jm050846j. J Med Chem. 2006. PMID: 16420061
Dopamine/serotonin receptor ligands, part III [1]: synthesis and biological activities of 7, 7'-alkylene-bis-6, 7, 8, 9, 14, 15-hexahydro-5H-benz[d]indolo[2, 3-g]azecines -- application of the bivalent ligand approach to a novel type of dopamine receptor antagonist.
Abadi AH, Lankow S, Hoefgen B, Decker M, Kassack MU, Lehmann J. Abadi AH, et al. Among authors: hoefgen b. Arch Pharm (Weinheim). 2002 Aug;335(8):367-73. doi: 10.1002/1521-4184(200211)335:8<367::AID-ARDP367>3.0.CO;2-C. Arch Pharm (Weinheim). 2002. PMID: 12397620